▶ 調査レポート

世界の異染性白質ジストロフィー（MLD）治療市場2019
• 英文タイトル：Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Report 2019

QYResearchが調査・発行した産業分析レポートです。世界の異染性白質ジストロフィー（MLD）治療市場2019 / Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Report 2019 / QYR9N2558資料のイメージです。• レポートコード：QYR9N2558
• 出版社/出版日：QYResearch / 2019年6月10日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、101ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥592,000 (USD4,000)▷ お問い合わせ
  Enterprise License￥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
本調査レポートでは、異染性白質ジストロフィー（MLD）治療の世界市場について調査・分析し、異染性白質ジストロフィー（MLD）治療のメーカー別販売量、市場シェア分析、種類別販売分析（AGT-183、DUOC-01、GSK-2696274、その他）、用途別販売分析（病院、診療所、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・異染性白質ジストロフィー（MLD）治療市場概要
・異染性白質ジストロフィー（MLD）治療のメーカー別販売量・メーカー別シェア
・異染性白質ジストロフィー（MLD）治療の種類別販売量（AGT-183、DUOC-01、GSK-2696274、その他）
・異染性白質ジストロフィー（MLD）治療の用途別販売量（病院、診療所、その他）
・異染性白質ジストロフィー（MLD）治療の地域別販売量・市場シェア
・異染性白質ジストロフィー（MLD）治療の米国市場規模（2014年-2019年）
・異染性白質ジストロフィー（MLD）治療のヨーロッパ市場規模（2014年-2019年）
・異染性白質ジストロフィー（MLD）治療の中国市場規模（2014年-2019年）
・異染性白質ジストロフィー（MLD）治療の日本市場規模（2014年-2019年）
・異染性白質ジストロフィー（MLD）治療の東南アジア市場規模（2014年-2019年）
・異染性白質ジストロフィー（MLD）治療のインド市場規模（2014年-2019年）
・異染性白質ジストロフィー（MLD）治療メーカー分析（企業概要、製品概要、販売量、売上、価格等）
・異染性白質ジストロフィー（MLD）治療のコスト分析
・異染性白質ジストロフィー（MLD）治療販売チャネル、流通業者、顧客
・異染性白質ジストロフィー（MLD）治療の世界市場動向・機会・成長要因・課題
・異染性白質ジストロフィー（MLD）治療の種類別世界市場予測（AGT-183、DUOC-01、GSK-2696274、その他）
・異染性白質ジストロフィー（MLD）治療の用途別世界市場予測（病院、診療所、その他）
・異染性白質ジストロフィー（MLD）治療の米国市場予測（2019年-2025年）
・異染性白質ジストロフィー（MLD）治療のヨーロッパ市場予測（2019年-2025年）
・異染性白質ジストロフィー（MLD）治療の中国市場予測（2019年-2025年）
・異染性白質ジストロフィー（MLD）治療の日本市場予測（2019年-2025年）
・異染性白質ジストロフィー（MLD）治療の東南アジア市場予測（2019年-2025年）
・異染性白質ジストロフィー（MLD）治療のインド市場予測（2019年-2025年）
...

The global Metachromatic Leukodystrophy (MLD) Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report studies the global Metachromatic Leukodystrophy (MLD) Treatment market status and forecast, categorizes the global Metachromatic Leukodystrophy (MLD) Treatment market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
ArmaGen Inc
GlaxoSmithKline Plc
Recursion Pharmaceuticals Inc
RegenxBio Inc
Shire Plc
…

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
AGT-183
DUOC-01
GSK-2696274
Others

Segment by Application
Hospital
Clinic
Others

レポート目次

Table of Contents

Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Report 2019
1 Metachromatic Leukodystrophy (MLD) Treatment Market Overview
1.1 Metachromatic Leukodystrophy (MLD) TreatmentProduct Overview
1.2 Metachromatic Leukodystrophy (MLD) Treatment Segment by Type
1.2.1 Global Metachromatic Leukodystrophy (MLD) Treatment Sales Comparison by Types (2014-2025)
1.2.2 AGT-183
1.2.3 DUOC-01
1.2.4 GSK-2696274
1.2.5 Others
1.3 Metachromatic Leukodystrophy (MLD) Treatment Segment by Application
1.3.1 Global Metachromatic Leukodystrophy (MLD) Treatment Sales Comparison by Application (2014-2025)
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Others
1.4 Metachromatic Leukodystrophy (MLD) Treatment Market by Region
1.4.1 Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Comparison by Region (2014-2025)
1.4.2 United States Metachromatic Leukodystrophy (MLD) Treatment Status and Prospect (2014-2025)
1.4.3 Europe Metachromatic Leukodystrophy (MLD) Treatment Status and Prospect (2014-2025)
1.4.4 China Metachromatic Leukodystrophy (MLD) Treatment Status and Prospect (2014-2025)
1.4.5 Japan Metachromatic Leukodystrophy (MLD) Treatment Status and Prospect (2014-2025)
1.4.6 Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Status and Prospect (2014-2025)
1.4.7 India Metachromatic Leukodystrophy (MLD) Treatment Status and Prospect (2014-2025)
1.5 Global Metachromatic Leukodystrophy (MLD) Treatment Sales and Revenue (2014-2025)
1.5.1 Global Metachromatic Leukodystrophy (MLD) Treatment Sales and Growth Rate (2014-2025)
1.5.2 Global Metachromatic Leukodystrophy (MLD) Treatment Revenue and Growth Rate (2014-2025)

2 Metachromatic Leukodystrophy (MLD) Treatment by Company, Region, Type and Application
2.1 Global Metachromatic Leukodystrophy (MLD) Treatment Market Competition by Companies
2.1.1 Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Company (2014-2019)
2.2 Global Metachromatic Leukodystrophy (MLD) Treatment Sales and Revenue by Region
2.2.1 Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Region (2014-2019)
2.2.2 Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Region (2014-2019)
2.3 Global Metachromatic Leukodystrophy (MLD) Treatment Sales and Revenue by Type
2.3.1 Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type (2014-2019)
2.3.2 Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Type (2014-2019)
2.4 Global Metachromatic Leukodystrophy (MLD) Treatment Sales by Application

3 United States Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue and Price
3.1 United States Metachromatic Leukodystrophy (MLD) Treatment Sales and Revenue (2014-2019)
3.1.1 United States Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Rate (2014-2019)
3.1.2 United States Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth Rate (2014-2019)
3.1.3 United States Metachromatic Leukodystrophy (MLD) Treatment Price Trend (2014-2019)
3.2 United States Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company
3.3 United States Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type
3.4 United States Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application

4 Europe Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue and Price
4.1 Europe Metachromatic Leukodystrophy (MLD) Treatment Sales and Value (2014-2019)
4.1.1 Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Rate (2014-2019)
4.1.2 Europe Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth Rate (2014-2019)
4.1.3 Europe Metachromatic Leukodystrophy (MLD) Treatment Price Trend (2014-2019)
4.2 Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company
4.3 Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type
4.4 Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application

5 China Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue and Price
5.1 China Metachromatic Leukodystrophy (MLD) Treatment Sales and Revenue (2014-2019)
5.1.1 China Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Rate (2014-2019)
5.1.2 China Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth Rate (2014-2019)
5.1.3 China Metachromatic Leukodystrophy (MLD) Treatment Price Trend (2014-2019)
5.2 China Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company
5.3 China Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type
5.4 China Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application

6 Japan Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue and Price
6.1 Japan Metachromatic Leukodystrophy (MLD) Treatment Sales and Value (2014-2019)
6.1.1 Japan Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Rate (2014-2019)
6.1.2 Japan Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth Rate (2014-2019)
6.1.3 Japan Metachromatic Leukodystrophy (MLD) Treatment Price Trend (2014-2019)
6.2 Japan Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company
6.3 Japan Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type
6.4 Japan Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application

7 Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue and Price
7.1 Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Sales and Value (2014-2019)
7.1.1 Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Price Trend (2014-2019)
7.2 Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company
7.3 Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type
7.4 Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application

8 India Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue and Price
8.1 India Metachromatic Leukodystrophy (MLD) Treatment Sales and Value (2014-2019)
8.1.1 India Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Rate (2014-2019)
8.1.2 India Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth Rate (2014-2019)
8.1.3 India Metachromatic Leukodystrophy (MLD) Treatment Price Trend (2014-2019)
8.2 India Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company
8.3 India Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type
8.4 India Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application

9 Company Profiles and Key Figures in Metachromatic Leukodystrophy (MLD) Treatment Business
9.1 ArmaGen Inc
9.1.1 ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Production Sites and Area Served
9.1.2 Metachromatic Leukodystrophy (MLD) Treatment Specification and Application
9.1.3 ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 GlaxoSmithKline Plc
9.2.1 GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Production Sites and Area Served
9.2.2 Metachromatic Leukodystrophy (MLD) Treatment Specification and Application
9.2.3 GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 Recursion Pharmaceuticals Inc
9.3.1 Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Production Sites and Area Served
9.3.2 Metachromatic Leukodystrophy (MLD) Treatment Specification and Application
9.3.3 Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 RegenxBio Inc
9.4.1 RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Production Sites and Area Served
9.4.2 Metachromatic Leukodystrophy (MLD) Treatment Specification and Application
9.4.3 RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 Shire Plc
9.5.1 Shire Plc Metachromatic Leukodystrophy (MLD) Treatment Production Sites and Area Served
9.5.2 Metachromatic Leukodystrophy (MLD) Treatment Specification and Application
9.5.3 Shire Plc Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
…

10 Metachromatic Leukodystrophy (MLD) Treatment Maufacturing Cost Analysis
10.1 Metachromatic Leukodystrophy (MLD) Treatment Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Metachromatic Leukodystrophy (MLD) Treatment
10.4 Metachromatic Leukodystrophy (MLD) Treatment Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Metachromatic Leukodystrophy (MLD) Treatment Distributors List
11.3 Metachromatic Leukodystrophy (MLD) Treatment Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Metachromatic Leukodystrophy (MLD) Treatment Market Forecast
13.1 Global Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue and Price Forecast
13.1.1 Global Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Forecast (2019-2025)
13.1.2 Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth Forecast (2019-2025)
13.1.3 Global Metachromatic Leukodystrophy (MLD) Treatment Price Trend Forecast (2019-2025)
13.2 Global Metachromatic Leukodystrophy (MLD) Treatment Forecast by Region
13.2.1 Global Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Metachromatic Leukodystrophy (MLD) Treatment Forecast by Type
13.3.1 Global Metachromatic Leukodystrophy (MLD) Treatment Sales Forecast by Type (2019-2025)
13.3.2 Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Forecast by Type (2019-2025)
13.3.3 Global Metachromatic Leukodystrophy (MLD) Treatment Price Forecast by Type (2019-2025)
13.4 Global Metachromatic Leukodystrophy (MLD) Treatment Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

List of Tables and Figures

Market Breakdown by Region: Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Value (Revenue: Million US$)
Market Breakdown by Type: Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Revenue (Million US$)
Market Breakdown by Application: Metachromatic Leukodystrophy (MLD) Treatment Sales (Jan)
Figure Metachromatic Leukodystrophy (MLD) Treatment Product Picture
Table Global Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) Growth Rate by Types (2014-2025)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Types in 2018
Figure AGT-183 Product Picture
Figure DUOC-01 Product Picture
Figure GSK-2696274 Product Picture
Figure Others Product Picture
Table Global Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) Comparison by Application (2014-2025)
Figure Global Sales Market Share of Metachromatic Leukodystrophy (MLD) Treatment by Application in 2018
Figure Hospital Examples
Figure Clinic Examples
Figure Others Examples
Table Global Market Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) Comparison by Region 2014-2025
Figure United States Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) Growth Rate (2014-2025)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) Growth Rate (2014-2025)
Table Global Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) of Key Companies (2014-2019)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Sales by Company in 2018
Table Global Metachromatic Leukodystrophy (MLD) Treatment Sales Share by Company (2014-2019)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Sales Share by Company in 2018
Table Global Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) by Company (2014-2019)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) by Company in 2018
Table Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Share by Company (2014-2019)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Share by Company in 2018
Table Global Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) Market Share by Region (2014-2019)
Table Global Metachromatic Leukodystrophy (MLD) Treatment Sales Share by Region (2014-2019)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Sales Share by Region in 2018
Table Global Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) Market Share by Region (2014-2019)
Table Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Share by Region (2014-2019)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Region In 2018
Table Global Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Type (2014-2019)
Table Global Metachromatic Leukodystrophy (MLD) Treatment Sales Share by Type (2014-2019)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Rate by Type in 2018
Table Global Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) Market Share by Type (2014-2019)
Table Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Share by Type (2014-2019)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth Rate by Type in 2018
Table Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application (2014-2019)
Table Global Metachromatic Leukodystrophy (MLD) Treatment Sales Share by Application (2014-2019)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application in 2018
Figure United States Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure United States Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure United States Metachromatic Leukodystrophy (MLD) Treatment Price (USD/Pcs) Trend (2014-2019)
Table United States Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Company (2014-2019)
Table United States Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company (2014-2019)
Figure United States Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company in 2018
Table United States Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Type (2014-2019)
Table United States Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type (2014-2019)
Figure United States Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type in 2018
Table United States Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Application (2014-2019)
Table United States Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application (2014-2019)
Figure United States Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application in 2018
Figure Europe Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure Europe Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Europe Metachromatic Leukodystrophy (MLD) Treatment Price (USD/Pcs) Trend (2014-2019)
Table Europe Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Company (2014-2019)
Table Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company (2014-2019)
Figure Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company in 2018
Table Europe Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Type (2014-2019)
Table Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type (2014-2019)
Figure Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type in 2018
Table Europe Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Application (2014-2019)
Table Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application (2014-2019)
Figure Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application in 2018
Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure China Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure China Metachromatic Leukodystrophy (MLD) Treatment Price (USD/Pcs) Trend (2014-2019)
Table China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Company (2014-2019)
Table China Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company (2014-2019)
Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company in 2018
Table China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Type (2014-2019)
Table China Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type (2014-2019)
Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type in 2018
Table China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Application (2014-2019)
Table China Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application (2014-2019)
Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application in 2018
Figure Japan Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure Japan Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Japan Metachromatic Leukodystrophy (MLD) Treatment Price (USD/Pcs) Trend (2014-2019)
Table Japan Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Company (2014-2019)
Table Japan Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company (2014-2019)
Figure Japan Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company in 2018
Table Japan Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Type (2014-2019)
Table Japan Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type (2014-2019)
Figure Japan Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type in 2018
Table Japan Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Application (2014-2019)
Table Japan Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application (2014-2019)
Figure Japan Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application in 2018
Figure Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Price (USD/Pcs) Trend (2014-2019)
Table Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Company (2014-2019)
Table Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company (2014-2019)
Figure Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company in 2018
Table Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Type (2014-2019)
Table Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type (2014-2019)
Figure Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type in 2018
Table Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Application (2014-2019)
Table Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application (2014-2019)
Figure Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application in 2018
Figure India Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure India Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure India Metachromatic Leukodystrophy (MLD) Treatment Price (USD/Pcs) Trend (2014-2019)
Table India Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Company (2014-2019)
Table India Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company (2014-2019)
Figure India Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company in 2018
Table India Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Type (2014-2019)
Table India Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type (2014-2019)
Figure India Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type in 2018
Table India Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Application (2014-2019)
Table India Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application (2014-2019)
Figure India Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application in 2018
Table ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Production Sites and Area Served
Table ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Specification and Application
Table ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Rate (2014-2019)
Figure ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Revenue Share in International Market (2014-2019)
Figure ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Main Business and Markets Served
Table GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Production Sites and Area Served
Table GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Specification and Application
Table GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Rate (2014-2019)
Figure GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Revenue Share in International Market (2014-2019)
Figure GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Main Business and Markets Served
Table Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Production Sites and Area Served
Table Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Specification and Application
Table Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Rate (2014-2019)
Figure Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Revenue Share in International Market (2014-2019)
Figure Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Main Business and Markets Served
Table RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Production Sites and Area Served
Table RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Specification and Application
Table RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Rate (2014-2019)
Figure RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Revenue Share in International Market (2014-2019)
Figure RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Main Business and Markets Served
Table Shire Plc Metachromatic Leukodystrophy (MLD) Treatment Production Sites and Area Served
Table Shire Plc Metachromatic Leukodystrophy (MLD) Treatment Specification and Application
Table Shire Plc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Shire Plc Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Rate (2014-2019)
Figure Shire Plc Metachromatic Leukodystrophy (MLD) Treatment Revenue Share in International Market (2014-2019)
Figure Shire Plc Metachromatic Leukodystrophy (MLD) Treatment Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Key Raw Materials Price Trend
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Metachromatic Leukodystrophy (MLD) Treatment
Figure Manufacturing Process Analysis of Metachromatic Leukodystrophy (MLD) Treatment
Figure Metachromatic Leukodystrophy (MLD) Treatment Industrial Chain Analysis
Table Metachromatic Leukodystrophy (MLD) Treatment Distributors List
Table Metachromatic Leukodystrophy (MLD) Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Price (USD/Pcs) and Trend Forecast (2019-2025)
Table Global Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) Forecast by Regions (2019-2025)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share Forecast by Regions (2019-2025)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share Forecast by Regions in 2025
Table Global Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) Forecast by Regions (2019-2025)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share Forecast by Regions (2019-2025)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share Forecast by Regions in 2025
Figure United States Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure United States Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Europe Metachromatic Leukodystrophy (MLD) Treatment Revenue and Growth Rate Forecast (2019-2025)
Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure China Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Japan Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure India Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure India Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) Forecast by Type (2019-2025)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share Forecast by Type (2019-2025)
Table Global Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share Forecast by Type (2019-2025)
Table Global Metachromatic Leukodystrophy (MLD) Treatment Price (USD/Pcs) Forecast by Type (2019-2025)
Table Global Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) Forecast by Application (2019-2025)
Figure Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の家族性腺腫性ポリポーシス治療市場2019
    Global Familial Adenomatous Polyposis Treatment Sales Market Report 2019
    QYR9N0916 2019年6月10日 100Pages
    本調査レポートでは、家族性腺腫性ポリポーシス治療の世界市場について調査・分析し、家族性腺腫性ポリポーシス治療のメーカー別販売量、市場シェア分析、種類別販売分析（イコサペント、塩酸エルフロニチン、アスピリン、CEQ-508、その他）、用途別販売分析（診療所、病院、その他）、地域別販売分析（米国、ヨーロ...
  • 世界の脂質障害治療市場2019
    Global Lipid Disorder Treatment Sales Market Report 2019
    QYR9N2276 2019年6月10日 105Pages
    本調査レポートでは、脂質障害治療の世界市場について調査・分析し、脂質障害治療のメーカー別販売量、市場シェア分析、種類別販売分析（アトルバスタチン、フルバスタチン、ロスバスタチン、シンバスタチン、プラバスタチン、その他の薬）、用途別販売分析（小売薬局、病院薬局、オンライン薬局）、地域別販売分析（米国、...
  • 世界の血漿プロテアーゼC1阻害剤治療市場2019
    Global Plasma Protease C1-inhibitor Treatment Sales Market Report 2019
    QYR9N3459 2019年6月13日 101Pages
    本調査レポートでは、血漿プロテアーゼC1阻害剤治療の世界市場について調査・分析し、血漿プロテアーゼC1阻害剤治療のメーカー別販売量、市場シェア分析、種類別販売分析（C1阻害剤、カリクレインインヒビター（Kalbitor）、選択的ブラジキニンB2受容体拮抗薬（Firazyr））、用途別販売分析（病院薬...
  • 世界の末期腎臓病治療市場2019
    Global End-Stage Kidney Disease Treatment Sales Market Report 2019
    QYR9N0792 2019年6月10日 105Pages
    本調査レポートでは、末期腎臓病治療の世界市場について調査・分析し、末期腎臓病治療のメーカー別販売量、市場シェア分析、種類別販売分析（MK-3866、パクリチニブ、サンギネート、テシドルマブ、その他）、用途別販売分析（診療所、病院、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、イ...
  • 世界のホモ接合型家族性高コレステロール血症の治療市場2019
    Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Report 2019
    QYR9N1684 2019年6月10日 107Pages
    本調査レポートでは、ホモ接合型家族性高コレステロール血症の治療の世界市場について調査・分析し、ホモ接合型家族性高コレステロール血症の治療のメーカー別販売量、市場シェア分析、種類別販売分析（AEM-2802、AEM-2814、アリロクマブ、エビナクマブ、その他）、用途別販売分析（診療所、病院、その他）...
  • 世界の眼の炎症治療市場2019
    Global Ocular Inflammation Treatment Sales Market Report 2019
    QYR9N2996 2019年6月13日 105Pages
    本調査レポートでは、眼の炎症治療の世界市場について調査・分析し、眼の炎症治療のメーカー別販売量、市場シェア分析、種類別販売分析（免疫抑制剤、モノクローナル抗体、コルチコステロイド、環状麻薬、抗生物質、その他）、用途別販売分析（小売薬局、病院薬局、オンライン薬局、ドラッグストア）、地域別販売分析（米国...
  • 世界のミトコンドリアミオパチーの診断と治療市場2019
    Global Mitochondrial Myopathy Diagnosis & Treatment Sales Market Report 2019
    QYR9N2675 2019年6月10日 102Pages
    本調査レポートでは、ミトコンドリアミオパチーの診断と治療の世界市場について調査・分析し、ミトコンドリアミオパチーの診断と治療のメーカー別販売量、市場シェア分析、種類別販売分析（遺伝子検査、筋肉生検）、用途別販売分析（支持療法、ターゲット療法）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア...
  • 世界の腱炎治療市場：市場規模・現状・予測
    Global Tendinitis Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8111 2019年6月14日 93Pages
    当資料は、腱炎治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・腱炎治療...
  • 世界のディンプル形成術の治療市場：市場規模・現状・予測
    Global Dimpleplasty Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7109 2019年6月14日 93Pages
    当資料は、ディンプル形成術の治療のグローバル市場について調査・分析したレポートで、種類別（光線療法、レーザー治療、その他）、用途別（病院、皮膚科クリニック、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界のフォンヴィレブランド病治療市場：市場規模・現状・予測
    Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8188 2019年6月14日 93Pages
    当資料は、フォンヴィレブランド病治療のグローバル市場について調査・分析したレポートで、種類別（ヴェイヴォンディ、フミン酸-P、英数字、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...
  • 世界のウィルムス腫瘍治療市場2019世界のウィルムス腫瘍治療市場2019 The global Wilms' Tumor Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Wilms' Tumor Treatment market status and forecast, categorizes the global Wilms' Tumor Treatment market size…
  • 世界の家族性腺腫性ポリポーシス治療市場2019世界の家族性腺腫性ポリポーシス治療市場2019 The global Familial Adenomatous Polyposis Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Familial Adenomatous Polyposis Treatment market status and forecast, categorizes the globa…
  • 世界の血漿プロテアーゼC1阻害剤治療市場2019世界の血漿プロテアーゼC1阻害剤治療市場2019 The global Plasma Protease C1-inhibitor Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Plasma Protease C1-inhibitor Treatment market status and forecast, categorizes the global Pl…
  • 世界の脂質障害治療市場2019世界の脂質障害治療市場2019 The global Lipid Disorder Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Lipid Disorder Treatment market status and forecast, categorizes the global Lipid Disorder Treatment marke…
  • 世界の野兎病治療市場2019世界の野兎病治療市場2019 The global Tularaemia Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Tularaemia Treatment market status and forecast, categorizes the global Tularaemia Treatment market size (valu…